Pancreatic cancer drug shows 41% response rate in clinical trial

The recent clinical trial of raludotatug deruxtecan has shown a promising 50.5% response rate in patients with ovarian cancer. This is significant as it highlights a potential new treatment option for a disease that often has limited effective therapies. The results could pave the way for further research and development, offering hope to many who are battling this challenging condition.

RAPT Therapeutics is set to unveil the results of its phase 2 trial for a new drug aimed at treating urticaria, a condition that causes hives and can significantly impact quality of life. This announcement is crucial as it could pave the way for new treatment options for patients suffering from this chronic condition, potentially improving their daily lives and offering hope for better management of symptoms.

Kelun-Biotech has announced promising results from its phase 3 clinical trial for a new breast cancer drug, which could significantly improve treatment options for patients. This development is crucial as it highlights advancements in cancer therapies, potentially leading to better outcomes and quality of life for those affected by the disease.

A recent clinical trial has shown that ENHERTU, a targeted therapy for breast cancer, achieved an impressive 92% invasive disease-free survival rate at the three-year mark. This significant finding highlights the potential of ENHERTU to improve outcomes for patients battling this challenging disease, offering hope for more effective treatment options in the future.

At the ESMO 2025 conference, the drug Enhertu has demonstrated the highest pathologic complete response (pCR) rate in patients with HER2-positive early breast cancer. This is significant as it highlights a promising advancement in treatment options for a challenging subtype of breast cancer, potentially improving outcomes for many patients.

Gedatolisib has demonstrated promising results in a recent breast cancer trial, showcasing its potential to improve treatment outcomes for patients. This development is significant as it offers hope for more effective therapies in a field that continually seeks advancements. With ongoing research, gedatolisib could become a vital option for those battling this challenging disease.

Exelixis has announced that its drug cabozantinib significantly reduces the risk of progression in lung and thymic neuroendocrine tumors (NET) by an impressive 81%. This breakthrough is crucial as it offers new hope for patients battling these challenging cancers, potentially improving their quality of life and survival rates. The findings from the clinical trial highlight the importance of innovative treatments in oncology, paving the way for further research and development in cancer therapies.

Genentech has announced promising results from its phase III trials for the UME treatment, which could significantly improve outcomes for patients. This development is crucial as it highlights advancements in medical research and the potential for new therapies that can enhance patient care and quality of life.

The ongoing conflict between Israel and Hamas has escalated, with Hamas reporting that at least 27 Palestinians have been killed by Israeli forces in the past week. Israeli officials counter that their troops acted to prevent incursions across the yellow line. This situation is critical as it not only highlights the deepening violence but also complicates efforts for peace in Gaza, raising concerns about the humanitarian impact on civilians.

In a tense meeting at the White House, President Trump reportedly urged Ukrainian President Zelenskyy to accept terms proposed by Russian President Putin, warning that failure to do so could lead to Ukraine's destruction by Russia. This alarming directive raises significant concerns about U.S. foreign policy and its implications for Ukraine's sovereignty, highlighting the precarious situation in Eastern Europe and the ongoing conflict with Russia.

Ed Miliband, the energy secretary, has suggested that the government should consider cutting VAT on energy bills to help alleviate the ongoing cost-of-living crisis. This proposal is significant as it aims to provide financial relief to households struggling with rising energy costs, highlighting the government's commitment to addressing economic challenges faced by citizens.

A reporter from the Epoch Times has resigned following the publication of new Pentagon rules that have raised concerns about press freedom. This resignation highlights ongoing tensions between media organizations and government regulations, emphasizing the challenges journalists face in maintaining independence while adhering to official guidelines. It matters because it reflects broader issues of transparency and accountability in government, which are crucial for a healthy democracy.

As the 2025-2026 NBA season approaches, excitement builds around potential award winners and dark horses. This article highlights predictions for the major regular-season awards, showcasing players like SGA and Wemby who are expected to shine. Understanding these predictions is crucial for fans and analysts alike, as they set the stage for the upcoming season and spark discussions about player performances.

In a heated exchange, former President Trump labeled Colombia's President Gustavo Petro a 'drug leader,' escalating tensions between the two leaders. This accusation follows Petro's earlier claims that the U.S. administration is responsible for murder due to its military actions in the Caribbean. This conflict is significant as it highlights the strained relations between the U.S. and Colombia, particularly regarding drug policy and military funding, which could impact future cooperation on security and anti-drug efforts.